A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
about
Interleukin 1 receptor antagonist. A new member of the interleukin 1 familyThe pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivoHuman CAP18: a novel antimicrobial lipopolysaccharide-binding proteinMucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteriaIn vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variantsInterleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbitsAn effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium.Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia.Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood.Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptidesLipopolysaccharide-induced lethality and cytokine production in aged mice.Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10.Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock.Role of interleukin-1 in infectious diseases.Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alphaInterleukin-1 is involved in mouse resistance to Mycobacterium avium.Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteriaGlomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.Interleukin-1 in lipopolysaccharide induced chorioamnionitis in the fetal sheep.Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.Interleukin 10 protects mice from lethal endotoxemiaPassive immunization of mice against D factor blocks lethality and cytokine release during endotoxemiaMice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock.IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide.Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury.Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist.Interleukin-8 in sepsis: relation to shock and inflammatory mediators.Inhibition of lipopolysaccharide-associated endotoxin activities in vitro and in vivo by the human anti-lipid A monoclonal antibody SdJ5-1.17.15.Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.Intraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr-1high polymorphonuclear neutrophils in the murine abdominal cavity.Endotoxin, cytokines, and hyperlipidemia.Interleukin-1: therapeutic potential for solid tumors.
P2860
Q24630432-F4C32FC8-51CC-4E7D-8B70-8635CEFEB0D5Q24682472-DA763293-89A6-489F-86FF-EA1E816F860DQ24682905-C4AF8798-AB50-43A5-8CA2-5DB563017ACEQ24799750-F242551E-D18D-45BA-A516-82D0AE48C79CQ30452859-1F263DFA-1C2A-4662-A20C-878EB9A21A1FQ33493710-B5EB516B-2421-4127-815A-8B7BC9D3978FQ33610571-474DEA78-64D0-411B-9A49-4EE5DBDF472EQ33753263-B870A163-5D96-491E-BFA5-AE7DE9609D0EQ33982156-32DDD824-1665-495D-A5C7-1B2EF5C30AC7Q34120115-95A20A63-03BF-4B39-86CF-E6ED44B9B8FEQ35131293-A423005E-E823-4CEC-9D61-A27E57279A19Q35378360-6C793406-07D2-4FF9-AD18-6983AFBB693DQ35472453-6A6F413F-7349-467F-8800-C31F56D535EFQ35545012-45E97937-FDF5-4741-9C38-1E4DFD3F40FCQ35558615-F9F6F287-ECF1-4ACF-8128-F004F954B5C2Q35732436-D6EE19CC-E105-4F9D-97C0-9471C116AC7BQ35764729-89965DDD-AF7E-4786-A65B-7DC1563801FFQ35772838-43ECF75C-38A1-46E7-B7ED-5822D1D034F0Q35822718-8BF883FC-4E62-4EE9-B735-E4DC9B1DFD4BQ35833791-A065984D-2125-403E-8516-F27539B45F62Q35931135-8E62C686-602A-45F8-AA87-4BE1622250D3Q36029062-E67E3465-ED31-4B2E-BE0C-FA92290CBE61Q36361322-EFD942D7-7AFA-4313-AC40-86724F015E1DQ36361558-C6A5B9AA-2511-4F1C-BF61-2C77832B6058Q36362194-2264D46E-8A7B-4BBA-BB2B-8B9D53A81089Q36366486-3E7287AC-2A32-478D-8BE3-5BD7280E491EQ36403308-304E4A60-8AB7-446F-B616-068A8EA857EEQ36928868-D0B847BD-4693-42DB-BAB8-4DB0473E083AQ37196942-B3EC0078-9F05-4E6B-B3A1-8E38DA149E2FQ37352036-2E92810E-5A3A-403F-B029-A49A70E303AAQ38820842-F4401389-82EF-425C-9864-93DA8AED047AQ39559351-3ECBAD17-BC8D-47BF-9327-91AC262E5ED1Q40147260-9DD4E46D-36E1-49BF-A443-9F94FDAEE8C3Q40268665-0BBB2612-72F7-4BFC-A3D1-2B77DABEA87CQ40337199-916300A7-D73D-4A58-836B-C200DBC78A9EQ40374245-B980E57F-2F96-4948-AF6B-BB27381BAE31Q40608792-22CD7A00-D63B-471B-BB06-EAF078DB49ABQ40833817-BC7DBB8D-59FB-4F09-A0A8-CAFB7A82A91BQ40851762-A7F475AE-AF6F-46B0-A14B-9B319AF2B664Q40860960-3B2831C7-A93F-48C2-AADA-837678A1ADDD
P2860
A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@ast
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@en
type
label
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@ast
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@en
prefLabel
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@ast
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@en
P2093
P2860
P356
P1476
A recombinant human receptor a ...... ter lethal endotoxemia in mice
@en
P2093
Alexander HR
Doherty GM
P2860
P304
P356
10.1084/JEM.173.4.1029
P407
P577
1991-04-01T00:00:00Z